About Us
Our journey, vision, and commitment to excellence.
Expertise in Catalytic Hydrogenation Since 1986
Transforming Technological Expertise into Industrial Reality
Founded in 1986 by three chemical engineers, Catapharma Group represents a passion for blending technological expertise with industrial success. Dr. Shrikant Karwa’s doctoral research on liquid-phase catalytic hydrogenation laid the foundation for the Group's evolution from a single product operation to a multi-product enterprise. Today, Catapharma employs 160+ professionals, operates two state-of-the-art manufacturing sites, and achieves an annual turnover of $20+ million.
Technological Expertise
At the heart of Catapharma’s success is its expertise in liquid-phase hydrogenation technology. With an in-house R&D lab and pilot plant, the Group has developed mastery in processes including Catalytic Hydrogenation, Oxidation, N-alkylation and O-alkylation, Nitrosation, Low-temperature Nitration, Esterification, Ethoxylation, etc.
This wide-ranging technological capability supports the Group’s innovative approach to chemical manufacturing.
Manufacturing Facilities
Our manufacturing facilities are strategically located across two industrial hubs in Maharashtra, India, ensuring robust production and efficient logistics.
Group Companies & Sites
-
Catapharma Chemicals Pvt. Ltd.STICE Sinnar, Nashik (Maharashtra)Established 1989 — Primary manufacturing hub.
-
MDB Chemicals (India) Pvt. Ltd.Erandol, Jalgaon (Maharashtra)Established 1997 — Dedicated unit for catechol derivatives.
In-house Capabilities
Both sites handle catalyst design, equipment design, and process development in-house. Our R&D and pilot plants enable seamless scale-up while ensuring quality through GC, HPLC, and Karl-Fischer analysis.
Strategic logistics: Both facilities have efficient access to JNPT Port, Mumbai for global exports.
Our Journey
Milestones and achievements across the decades.
Founding
Financed by Venture capital of IDBI for pilot plant of Paracetamol from nitrobenzene using selective catalytic hydrogenation.
First manufacturing site
Comissioning of manufacturing plant for pharma and dye intermediates using green catalytic hydrogenation technology.
Application of Green Chemistry
Developed green chemistry routes for over 50 products, reducing India's import dependence and establishing roots in foreign markets.
Second Manufacturing Site
Comissioning of Export Oriented Unit for catechol derivatives.
1-Methyl-3-phenyl piperazine
With a capacity of 80 MTA, became a major supplier to manufacturers of Mirtazapine.
trans and cis-N-BOC-4-Amino Cyclohexane Carboxylic Acid
With a capacity of 30 MTA, became a major supplier to manufacturers of Oclacitinib.
1,2-Methylenedioxy benzene
With a capacity of 3000 MTA, became a largest supplier to the Agrochemicals, Perfumery and Pharma industries.
1-Amino-4-methyl piperazine
With 300 MTA capacity, became a largest supplier to manufacturers of Rifampicin globally. With new use as a substitute for Hydrazine in boiler water treatment, it's consumption is increasing year after year.
N‑Benzyl Ethanolamine
With a capacity of 300 MTA, became the most sought after by manufacturers of Cyclen (Intermediate for MRI contrast agents)
1-Amino-4-cyclopentyl piperazine
Developed for inventor of Rifapentine in 2011, and commercialized as the exclusive supplier globally with a capacity of 48 MTA.
N,N’-Di-t-Butyl ethylenediamine & N,N-Dimethyl butylamine
Established major capacity.Founding
Financed by Venture Capital of IDBI for pilot plant of Paracetamol from nitrobenzene using selective catalytic hydrogenation.
First manufacturing site
Comissioning of manufacturing plant for pharma and dye intermediates using green catalytic hydrogenation technology.
Application of Green Chemistry
Developed green chemistry routes for over 50 products, reducing India's import dependence and establishing roots in foreign markets.
Second Manufacturing Site
Comissioning of Export Oriented Unit for catechol derivatives.
1-Methyl-3-phenyl piperazine
With a capacity of 80 MTA, became a major supplier to manufacturers of Mirtazapine.
trans and cis-N-BOC-4-Amino Cyclohexane Carboxylic Acid
With a capacity of 30 MTA, became a major supplier to manufacturers of Oclacitinib.
1,2-Methylenedioxy benzene
With a capacity of 3000 MTA, became a largest supplier to the Agrochemicals, Perfumery and Pharma industries.
1-Amino-4-methyl piperazine
With 300 MTA capacity, became a largest supplier to manufacturers of Rifampicin globally. With new use as a substitute for Hydrazine in boiler water treatment, it's consumption is increasing year after year.
N‑Benzyl Ethanolamine
With a capacity of 300 MTA, became the most sought after by manufacturers of Cyclen (Intermediate for MRI contrast agents)
1-Amino-4-cyclopentyl piperazine
Developed for inventor of Rifapentine in 2011, and commercialized as the exclusive supplier globally with a capacity of 48 MTA.
N,N'-Di-t-Butyl ethylenediamine & N,N-Dimethyl butylamine
Established major capacity.Global Certifications
Our facilities are certified by leading global bodies for sustainability, safety, and purity standards, including Ecovadis, EU REACH, Halal, and Kosher.
Industry Recognition
Catapharma has been consistently recognized for its pioneering work in Green Chemistry and its contribution to the global pharmaceutical industry over four decades.